CollabRx combines revolutionary advances in computational and high throughput biology with Web-based collaborative science to slash the time, cost and risk of therapy development. The CollabRx research platform connects scientists with a global network of top research labs, clinicians and contract research organizations. Our mission at CollabRx is to find treatments for rare and orphan diseases within the lifetimes and collective means of current patients. CollabRx enables scientists to work collaboratively on behalf of patients and their doctors who urgently seek cures for their diseases.
For Oncologists and Patients For Biomedical Researchers News and Events

Introducing CollabRx ONE, a Personalized Oncology Research Program. We use state-of-the-art molecular and computational methods to profile the tumor and to identify potential treatments among thousands of approved and investigational drugs. Learn more.

The CollabRx Bioinformatics Platform is a web-based service that enables distributed groups of collaborating scientists to systematically and rapidly explore the opportunity space of targets and leads based on all available knowledge and resources. Learn more.

May 2009
CollabRx founder Marty Tenenbaum interviewed on "Open Science" on the "A World of Possibilities" radio program.

February 2009
CollabRx founder Marty Tenenbaum delivers keynote, "Therapy Development in the Network Age," at Molecular Medicine Tri-conference

Leave no stone unturned.
Contact CollabRx.

Call 650.681.4581
or send us email.
Interested in learning more about the latest developments at CollabRx?
Sign up to receive updates.

CollabRx does not share personal information collected on this site.